2 recruiting. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Recruiting 2 |
Follow Failure to Thrive: new trials by email Literature Review of Failure to Thrive trials Research Report on Failure to Thrive
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Trial Investigating the Efficacy and Safety of Weekly Lonapegsomatropin Compared to Daily Somatropin in Children and Adolescents With Short Stature or Growth Failure Due to Growth Hormone Sufficient Disorders Lonapegsomatropin [SKYTROFA®], Somatropin Pen Injector - Turner Syndrome, Short Stature Homeobox Gene Mutation | Phase 3 | Recruiting | Ascendis Pharma A/S | 186 | 2025-12-12 | 2026-11-05 |
| Randomized Clinical Trial of Two Different Initial Growth Hormone Doses in Children Somatropin - Growth Disorders, Growth Failure | Phase 3 | Recruiting | Northwell Health | 50 | 2023-12-10 | 2026-10-21 |
Chromosome Disorders (1) · Dwarfism (1) · Endocrine System Diseases (1) · Growth Disorders (1) · Noonan Syndrome (1) · Sex Chromosome Disorders (1) · Sex Chromosome Disorders of Sex Development (1) · Turner Syndrome (1)
Pathological Conditions, Signs and Symptoms (2) · Signs and Symptoms (2) · Bone Diseases (1) · Bone Diseases, Developmental (1) · Cardiovascular Abnormalities (1) · Cardiovascular Diseases (1) · Congenital Abnormalities (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Connective Tissue Diseases (1) · Craniofacial Abnormalities (1) · Disorders of Sex Development (1) · Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Genetic Diseases, Inborn (1) · Gonadal Disorders (1)
Growth Hormone (1) · Human Growth Hormone (1) · lonapegsomatropin (1)
Ascendis Pharma A/S (1) · Northwell Health (1)
United States (2) · France (1) · Germany (1) · Italy (1) · Romania (1) · South Korea (1) · Spain (1)